Podcast

Lisa Swanson, MD: Unlocking the Pediatric Dermatology Toolbox

Author(s):

Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.

The field of pediatric dermatology certainly does not fall short in its breadth and depth of topics.

It goes without saying that many of the conditions faced by adults can impact children just the same. A pediatric dermatologist may have to deal with conditions like atopic dermatitis, molluscum and warts, tinea capitis, psoriasis, and hemangiomas, among others.

Of course, each issue presents its own set of challenges and may require unique approaches to treatment and management.

In this next episode of Derm Discussions, host Brad Glick, DO, FAAD, Assistant Clinical Professor of Dermatology, Herbert Wertheim College of Medicine, talked with Lisa Swanson, MD, a board-certified pediatric dermatologist, about a variety of dermatological conditions that are common—and not-so-common—in pediatric patients.

Drawing directly from her clinical experience, Swanson provided insight into treatment strategies for a range of conditions—such as atopic dermatitis, psoriasis, and acne. She also talked about new and exciting therapies within the field of dermatology, many of which have indications extended to young patients.

“Getting the approval down to 4 or 6 or wherever it might be not only makes it easier for pediatric dermatologists to treat these kids, but I think it gives everybody a better comfort level with the medicines,” she said.

Swanson covered vast terrain in discussing the promising future of pediatric dermatology and the challenges that still remain.

Related Videos
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
© 2024 MJH Life Sciences

All rights reserved.